Topiramate as an add‐on antiepileptic drug in treating refractory canine idiopathic epilepsy
- 23 August 2013
- journal article
- clinical trial
- Published by Wiley in Journal of Small Animal Practice
- Vol. 54 (10) , 512-520
Abstract
Objectives: To evaluate the efficacy and safety of topiramate as an add‐on therapy in dogs with refractory idiopathic epilepsy.Method: Prospective, open label, non‐comparative clinical trial of topiramate in dogs with idiopathic epilepsy and poor seizure control despite therapeutic serum concentrations of phenobarbital and potassium bromide. The efficacy of topiramate was evaluated by comparing seizure and seizure day frequencies during a retrospective 2‐month period with a prospective short‐term follow‐up of 6 months. An additional long‐term follow‐up period ranging from 3 to 9 months was conducted on dogs that responded to topiramate therapy during the short‐term follow‐up.Results: Ten dogs were included. Five (50%) responded to topiramate therapy during the short‐term follow‐up showing a significant (P=0·04) decrease of 66% in seizure frequency. Three of the five dogs remained responders during the long‐term follow‐up. Weight loss, sedation and ataxia were the most common adverse effects of topiramate therapy, but in dogs with moderate sedation or ataxia, signs subsided in a few weeks to few months to mild sedation or ataxia.Clinical Significance: Topiramate may be effective as an add‐on medication in treating canine idiopathic epilepsy. Apart from sedation and ataxia reported in some of the dogs, topiramate was well‐tolerated.Keywords
This publication has 38 references indexed in Scilit:
- Placebo Effect in Canine Epilepsy TrialsJournal of Veterinary Internal Medicine, 2010
- Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsyJournal of the American Veterinary Medical Association, 2009
- Serum triglyceride concentration in dogs with epilepsy treated with phenobarbital or with phenobarbital and bromideJournal of the American Veterinary Medical Association, 2008
- Premature Death, Risk Factors, and Life Patterns in Dogs with EpilepsyJournal of Veterinary Internal Medicine, 2007
- Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogsJournal of Small Animal Practice, 2007
- Liver‐related biochemical changes in the serum of dogs being treated with phenobarbitoneVeterinary Record, 2003
- Topiramate in Lennox–Gastaut Syndrome: Open‐Label Treatment of Patients Completing a Randomized Controlled TrialEpilepsia, 2000
- Nonfocal Generalized Tonic–Clonic Seizures: Response During Long‐Term Topiramate TreatmentEpilepsia, 2000
- Effectiveness, Tolerability, and Safety of Topiramate in Children with Partial‐Onset SeizuresEpilepsia, 2000
- Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparisonJournal of Veterinary Pharmacology and Therapeutics, 1985